NIFTY 50▲22,402.40
34.40 (0.15%)
SENSEX▲73,852.94
114.49 (0.16%)
NIFTY BANK▲48,189.00
218.55 (0.46%)
TATA MOTORS▲991.65
4.90 (0.50%)
INDIAN RAILWAY FINANCE CORP▲149.00
1.25 (0.85%)
SUZLON ENERGY▼41.80
-0.05 (-0.12%)
TATA POWER▼428.30
-1.35 (-0.31%)
TATA STEEL▲165.55
4.40 (2.73%)
YES BANK▼25.45
-0.20 (-0.78%)
INDIAN RENEWABLE ENERGY▼166.60
-1.35 (-0.80%)
RELIANCE INDUSTRIES▼2,900.35
-18.30 (-0.63%)
RELIANCE POWER▼27.60
-0.40 (-1.43%)
VODAFONE IDEA▼13.10
-1.30 (-9.03%)
HDFC BANK▲1,511.70
4.10 (0.27%)
JIO FIN SERVICES LTD▼381.85
-6.10 (-1.57%)
RAIL VIKAS NIGAM▲284.25
6.90 (2.49%)
ADANI POWER▼596.50
-5.95 (-0.99%)
ZOMATO▼184.40
-3.05 (-1.63%)
NHPC▲90.25
0.50 (0.56%)
STATE BANK OF INDIA▲773.10
0.10 (0.01%)
INDIAN RAILWAY TOURISM CORP▲1,025.35
9.05 (0.89%)
INDIAN OIL CORP▲168.75
0.65 (0.39%)
MRF▼1,28,524.45
-702.25 (-0.54%)
ITC▼428.90
-0.30 (-0.07%)
ADANI GREEN ENERGY▼1,808.30
-8.10 (-0.45%)
JAIPRAKASH POWER VENTURES▼18.05
-0.20 (-1.10%)
ADANI ENTERPRISES▼3,043.55
-21.55 (-0.70%)
ADANI PORT & SEZ▼1,320.50
-1.60 (-0.12%)
Mankind Pharma Share Price
MANKIND
₹2,398.30+₹5.25 (0.22%) Past YearLast updated on 24 Apr, 2024 | 03:48 PM IST
₹2,375.00₹2,440.80
LH
What’s in news?
Company overview
About
Market cap
| Open₹2,410.95 | Close₹2,393.05 |
Circuit range₹2,632.35 - ₹2,153.75 | Day range₹2,375.00 - ₹2,440.80 | Year range₹1,242.00 - ₹2,490.00 |
Volume5,69,613 | Avg. traded₹2,399.71 | Revenue (12m)₹9,946 Cr |
Mankind PharmaMankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.
Read more
Mankind Pharma Key indicators
52 week high₹2,490.00 | 52 week low₹1,242.00 | P/E ratio55.55 |
P/B ratio10.79 | ROE17.43% | ROCE21.2% |
Dividend yield-- | Debt/Equity ratio | EPS31.16 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
50%
Hold
30%
Sell
20%
This analysis is based on the reviews of 10 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin21.96% | Net profit margin14.73% |
ROE17.43% | ROA13.63% |
ROCE21.2% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Mankind Pharma Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Tue, Apr 23 2024 | ₹2,369.90 | ₹2,393.05 | |
Mon, Apr 22 2024 | ₹2,341.85 | ₹2,340.40 | -0.06% |
Fri, Apr 19 2024 | ₹2,350.05 | ₹2,337.45 | -0.54% |
Thu, Apr 18 2024 | ₹2,290.95 | ₹2,395.65 | |
Tue, Apr 16 2024 | ₹2,247.35 | ₹2,281.05 | |
Mon, Apr 15 2024 | ₹2,256.00 | ₹2,267.35 | |
Fri, Apr 12 2024 | ₹2,348.25 | ₹2,320.35 | -1.20% |
Wed, Apr 10 2024 | ₹2,375.95 | ₹2,368.75 | -0.30% |
Events
No data available at the moment
More
Similar stocks
No data available at the moment
People also bought
No data available at the moment